Abstract:Background: The COVID-19 pandemic has killed over 6 million people worldwide. Despite the accumulation of knowledge about the causative pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the pathogenesis of this disease, cures remain to be discovered. We searched for certain peptides that might interfere with spike protein (S protein)-angiotensin-converting enzyme 2 (ACE2) interactions. Methods: Phage display (PhD)-12 peptide library was screened against recombinant spike trimer (S-trimer) or receptor-binding domain (S-RBD) proteins. The resulting enriched peptide sequences were obtained, and their potential binding sites on S-trimer and S-RBD 3D structure models were searched. Synthetic peptides corresponding to these and other reference sequences were tested for their efficacy in blocking the binding of S-trimer protein onto recombinant ACE2 proteins or ACE2-overexpressing cells. Results: After three rounds of phage selections, two peptide sequences (C2, DHAQRYGAGHSG; C6, HWKAVNWLKPWT) were enriched by S-RBD, but only C2 was present in S-trimer selected phages. When the 3D structures of static monomeric S-RBD (6M17) and S-trimer (6ZGE, 6ZGG, 7CAI, and 7CAK, each with different status of S-RBDs in the three monomer S proteins) were scanned for potential binding sites of C2 and C6 peptides, C6 opt to bind the saddle of S-RBD in both 6M17 and erected S-RBD in S-trimers, but C2 failed to cluster there in the S-trimers. In the competitive S-trimer-ACE2-binding experiments, synthetic C2 and C6 peptides inhibited S-trimer binding onto 293T-ACE2hR cells at high concentrations (50 μM) but not at lower concentrations (10 μM and below), neither for the settings of S-trimer binding onto recombinant ACE2 proteins. Conclusion: Using PhD methodology, two peptides were generated bearing potentials to interfere with S protein-ACE2 interaction, which might be further exploited to produce peptidomimetics that block the attachment of SARS-CoV-2 virus onto host cells, hence diminishing the pathogenesis of COVID-19.

Screening and Identification of Linear B-Cell Epitopes and Entry-Blocking Peptide of Severe Acute Respiratory Syndrome (Sars)-Associated Coronavirus Using Synthetic Overlapping Peptide Library

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

Selection of SARS-Coronavirus-specific B Cell Epitopes by Phage Peptide Library Screening and Evaluation of the Immunological Effect of Epitope-Based Peptides on Mice

Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.

Assessment Of Immunoreactive Synthetic Peptides From The Structural Proteins Of Severe Acute Respiratory Syndrome Coronavirus

Antibody Binding Site Mapping Of Sars-Cov Spike Protein Receptor-Binding Domain By A Combination Of Yeast Surface Display And Phage Peptide Library Screening

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS.

A Strategy for Searching Antigenic Regions in the SARS-CoV Spike Protein

Phages Bearing Affinity Peptides to Severe Acute Respiratory Syndromes-Associated Coronavirus Differentiate This Virus from Other Viruses

Screening and identification of mimotope of the SARS-CoV spike protein by phage peptide library

Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library

Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines

Biopanning of specific peptide for SARS-CoV-2 nucleocapsid protein and enzyme-linked immunosorbent assay-based antigen assay

Identification Of Immunodominant Epitopes On The Membrane Protein Of The Severe Acute Respiratory Syndrome-Associated Coronavirus

Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2

B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target A Dominant Site in the S2 Domain of the Surface Spike Glycoprotein

Identification of Three Conserved Linear B Cell Epitopes on the SARS-CoV-2 Spike Protein

Development of Human Single-Chain Antibodies Against Sars-Associated Coronavirus